Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

LLY

Lilly(Eli) & Co

Jan 17 • 04:00PM ET

725.72

Dollar change -31.88
Percentage change -4.21	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE MRK JNJ BMY GILD AMGN ABBV REGN BIIB VRTX

| Held by: VTI VOO SPY IVV VUG XLV IWF VHT QUAL IVW

Scroll to Statements

Index	S&P 500	P/E	79.39	EPS (ttm)	9.14	Insider Own	10.39%	Shs Outstand	950.22M	Perf Week	-9.27%
Market Cap	688.94B	Forward P/E	32.19	EPS next Y	22.55	Insider Trans	-0.05%	Shs Float	850.66M	Perf Month	-6.84%
Income	8.37B	PEG	2.41	EPS next Q	5.30	Inst Own	72.75%	Short Float	0.72%	Perf Quarter	-20.81%
Sales	40.86B	P/S	16.86	EPS this Y	105.88%	Inst Trans	5.54%	Short Ratio	1.50	Perf Half Y	-14.51%
Book/sh	14.99	P/B	48.43	EPS next Y	73.28%	ROA	12.54%	Short Interest	6.10M	Perf Year	15.39%
Cash/sh	3.71	P/C	195.81	EPS next 5Y	33.00%	ROE	65.75%	52W Range	612.70 - 972.53	Perf YTD	-5.99%
Dividend Est.	5.34 (0.74%)	P/FCF	492.17	EPS past 5Y	13.74%	ROI	19.34%	52W High	-25.38%	Beta	0.41
Dividend TTM	5.20 (0.72%)	Quick Ratio	0.97	Sales past 5Y	11.42%	Gross Margin	80.91%	52W Low	18.45%	ATR (14)	23.29
Dividend Ex-Date	Feb 14, 2025	Current Ratio	1.27	EPS Y/Y TTM	68.88%	Oper. Margin	35.33%	RSI (14)	35.08	Volatility	3.94% 2.70%
Employees	43000	Debt/Eq	2.19	Sales Y/Y TTM	27.41%	Profit Margin	20.48%	Recom	1.56	Target Price	1000.19
Option/Short	Yes / Yes	LT Debt/Eq	2.04	EPS Q/Q	1780.56%	Payout	77.91%	Rel Volume	1.35	Prev Close	757.60
Sales Surprise	-5.44%	EPS Surprise	-16.97%	Sales Q/Q	20.43%	Earnings	Feb 06 BMO	Avg Volume	4.07M	Price	725.72
SMA20	-6.14%	SMA50	-7.27%	SMA200	-13.53%	Trades		Volume	5,485,683	Change	-4.21%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525
Jul-14-23	Initiated	HSBC Securities	Buy	$560
May-24-23	Reiterated	UBS	Buy	$447 → $498
May-24-23	Reiterated	BofA Securities	Buy	$450 → $500
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$360 → $375
Mar-06-23	Initiated	Jefferies	Hold	$290
Feb-15-23	Downgrade	Societe Generale	Hold → Sell
Nov-18-22	Initiated	Credit Suisse	Outperform	$395
Sep-22-22	Upgrade	UBS	Neutral → Buy	$335 → $363

Show Previous Ratings

Today 05:13PM	The Score: Goldman Sachs, Nvidia, UnitedHealth and More Stocks That Defined the Week (The Wall Street Journal)
05:03PM	S&P 500 Gains and Losses Today: Intel Stock Soars as Takeover Speculation Spreads (Investopedia)
04:13PM	Medicare to negotiate prices on 15 drugs, including Ozempic (Yahoo Finance Video)
01:55PM	Here's How Donald Trump Could Shake Up Health Care And Biotech Stocks (Investor's Business Daily)
01:07PM	Why NVO and LLY Are Dropping Today (Insider Monkey)
11:38AM	Loading…
11:38AM	Novo Nordisk Stumbles as Eli Lilly Tightens Grip on the Obesity Drug Market (GuruFocus.com)
11:10AM	Ozempic Among the Next Drugs Up for Medicare Price Negotiations (The Wall Street Journal)
08:00AM	FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease (Benzinga)
07:30AM	Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever (Motley Fool)
04:05AM	Could Donald Trump Make Eli Lilly Stock a No-Brainer Buy in 2025? (Motley Fool)
Jan-16-25 05:57PM	JPM 2025: WuXi AppTec rebuffs concern about lower GLP-1 demand after Lillys low revenue forecast (Pharmaceutical Technology)
10:06AM	Eli Lilly Stock Has Tumbled 22% Since Its August High. Is It A Buy Or A Sell? (Investor's Business Daily)
05:26AM	Lillys Omvoh approved by FDA for Crohns (BioPharma Dive)
04:05AM	Lilly gains US FDA approval for Omvoh to treat Crohns disease (Pharmaceutical Technology)
03:56AM	JPM25: The FDAs future, AbbVies second thoughts and Lillys lesson (BioPharma Dive)
03:15AM	Loading…
03:15AM	My 10 Top Stocks to Buy to Start the New Year Off Right (Motley Fool)
02:10AM	By the numbers: J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years (Pharma Voice)
Jan-15-25 04:45PM	These Stocks Moved the Most Today: JPMorgan, Wells Fargo, Goldman, Citigroup, BlackRock, Quantum Computing, and More (Barrons.com)
04:31PM	Eli Lilly Receives FDA Approval for Crohns Disease Treatment (The Wall Street Journal)
04:23PM	After Eli Lilly's 7% Slump On Its Guidance Cut, What's Left To Like? A Lot, Says One Analyst. (Investor's Business Daily)
04:06PM	FDA approves Lilly's Omvoh (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease (PR Newswire)
02:37PM	These Stocks Are Moving the Most Today: JPMorgan, Wells Fargo, Goldman, Citigroup, BlackRock, Quantum Computing, and More (Barrons.com)
12:50PM	Jim Cramer on Eli Lilly and Company (LLY): Theres Been Some Mistakes (Insider Monkey)
10:58AM	Cramer's Mad Dash: Eli Lilly (CNBC TV)
10:23AM	Eli Lilly: What's Left To Like? A Lot, Says One Analyst. (Investor's Business Daily)
09:47AM	As Lilly Stock Tumbles on GLP-1 Demand Worries, CEO Says All Is Well (Barrons.com)
09:47AM	As Lilly Stock Tumble on GLP-1 Demand Worries, CEO Says All Is Well (Barrons.com)
09:00AM	Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock (Zacks)
08:36AM	Option Trade Could Return More Than $1,300 On A Wobbly Eli Lilly (Investor's Business Daily)
08:15AM	Has Eli Lilly Stock Peaked? (Motley Fool)
08:09AM	Loading…
08:09AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:32AM	JP Morgan 2025: Eli Lilly misses 2024 revenue estimate by $400m (Pharmaceutical Technology)
06:55AM	Eli Lilly Stumbled But Weight-Loss Drugs Will Continue to Fuel Markets. Heres Why and 5 Other Things to Know Today. (Barrons.com)
Jan-14-25 10:04PM	Watch These Eli Lilly Price Levels as Stock Slumps on Tepid Sales Outlook (Investopedia) -6.59%
09:12PM	Analyst Report: Eli Lilly and Company (Morningstar Research)
06:55PM	Buy the weakness in Eli Lilly, says Mizuho Healthcare Strategist Jared Holz (CNBC TV)
05:17PM	Wall Street Traders Hold Their Breath Before CPI: Markets Wrap (Bloomberg)
05:11PM	S&P 500 Gains and Losses Today: Eli Lilly Stock Falls as Sales Outlook Weakens (Investopedia)
03:03PM	Eli Lillys Zepbound and Mounjaro Sales Missed Estimates Again. The Wobbles Looking Serious. (Barrons.com)
02:00PM	Eli Lilly stock tumbles after new forecasts show weight-loss drug sales grow slower than expected (Yahoo Finance)
02:00PM	Eli Lilly stock down on Q4 guidance miss (Yahoo Finance)
01:59PM	Eli Lilly Stock Slumps on Lowered Sales Forecast (Investopedia)
01:54PM	Lilly Stock Drops 7% as 2024 Revenue Projection Falls Short of Guidance (GuruFocus.com)
01:40PM	Final Trades: Reddit, Delta, Thermo Fisher and Eli Lilly (CNBC TV)
01:19PM	Eli Lilly Cuts Q4 Forecast Amid Weak Sales but Sees Bright 2025 with $61B Revenue Potential (GuruFocus.com)
01:18PM	Structure CEO on Obesity Drugs: Oral Pills Are the Solution (Bloomberg)
12:46PM	Lilly Sales Miss on Slower-Than-Expected Obesity Shot Demand (Bloomberg)
12:45PM	Eli Lilly CEO on prospect of insurance companies covering weight loss drugs (CNBC TV)
12:18PM	Eli Lilly was hoping weight loss drug demand would be even bigger (Quartz)
12:12PM	Eli Lilly Shares Down 7.5% as Market Reacts to Slashed Q4 Forecast (GuruFocus.com)
12:11PM	Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday (Motley Fool)
11:56AM	Top Stock Movers Now: United Rentals, KB Home, Eli Lilly, and More (Investopedia)
11:25AM	Eli Lilly Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow (Investor's Business Daily)
11:20AM	China stocks, Trump Media shares, Eli Lilly: Market Minute (Yahoo Finance Video)
10:53AM	Eli Lilly misses 2024 revenue numbers, but GLP-1 pill may help (Yahoo Finance Video)
10:24AM	Why Eli Lilly (LLY) Stock Is Declining Today (Insider Monkey)
10:11AM	Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks (Benzinga)
10:07AM	Eli Lilly Cuts Sales Outlook After Sluggish Growth for Incretin Drugs (The Wall Street Journal)
09:33AM	Lilly forecasts weak fourth-quarter sales of weight-loss drug, shares slump (Reuters)
09:28AM	Eli Lilly issues 2025 revenue forecast ahead of market estimates (Investing.com)
09:00AM	Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance (PR Newswire)
08:54AM	Hengrui and Kailera report best-in-class data from Phase II GLP-1/GIP trial (Clinical Trials Arena)
Jan-13-25 07:32PM	Eli Lilly targets Scorpion Therapeutics to expand reach in oncology (Pharmaceutical Technology)
05:45PM	Eli Lilly (LLY) Stock Declines While Market Improves: Some Information for Investors (Zacks)
04:06PM	Healthcare M&A poised for a rebound in 2025 (Yahoo Finance Video)
03:13PM	Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal (The Wall Street Journal)
01:30PM	Drugmakers will ask US government to pause drug price negotiations, Bloomberg News reports (Reuters)
11:41AM	Eli Lilly's weight loss pill could get federal approval by early next year (Quartz)
10:57AM	Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. (Investor's Business Daily)
09:31AM	Eli Lilly to Buy Scorpion Therapeutics Drug Program in $2.5 Billion Deal (The Wall Street Journal)
09:10AM	Eli Lilly to buy Scorpion Therapeutics' cancer therapy for up to $2.5 billion (Reuters)
09:00AM	Lilly to acquire Scorpion Therapeutics' mutant-selective PI3K inhibitor program (PR Newswire)
04:42AM	Mediar Therapeutics signs licensing deal with Eli Lilly for IPF treatment (Pharmaceutical Technology)
04:36AM	Lilly pads cancer drug pipeline with Scorpion deal (BioPharma Dive)
Jan-11-25 01:00PM	FDA Approves Weight-loss Drug Zepbound For Sleep Apnea Will Insurance Cover This $1000-Per-Month Medication? (Benzinga)
Jan-10-25 08:30AM	AI, vaccine distrust, & the future of healthcare: Novartis CEO (Yahoo Finance Video)
06:25AM	Alzheimers Drugs Eyed as Next Big Obesity-Like Opportunity (Bloomberg)
05:30AM	Trump Says World Is Free-Riding on U.S. Health Spending. He Has a Point. (The Wall Street Journal)
Jan-09-25 07:34PM	Eli Lilly (LLY) Vs Novo Nordisk (NVO): Which is the Best Weight Loss Stock for 2025? (Zacks)
04:02PM	Is Eli Lilly and Company (LLY) the Best Blue Chip Stock to Buy for 2025? (Insider Monkey)
03:36PM	Eli Lilly's Zepbound Can Now Be Covered by Medicare to Treat Sleep Apnea (Investopedia)
11:53AM	Medicare Will Pay for Zepbound for Some Patients. The Costs Could Be Huge. (Barrons.com)
08:40AM	Exclusive: Arianna Huffingtons Thrive Global inks novel partnership with pharma giant Eli Lilly (Fortune)
08:00AM	Is Eli Lilly Stock A Buy Or A Sell After Its Weight-Loss Drug Scores A Major Victory? (Investor's Business Daily)
07:13AM	5 questions facing pharma in 2025 (BioPharma Dive)
05:00AM	The most and least expensive weight loss drugs, ranked (Quartz)
04:34AM	3 Stocks to Buy for 2025 That Are Practically Money Machines (Motley Fool)
Jan-08-25 05:05PM	Zepbound can now be covered by Medicare (Quartz)
04:44PM	Less than 50% of employers cover GLP-1 drugs for weight loss: JPM survey (Yahoo Finance)
02:16PM	Novo Nordisk Received an Upgrade from UBS for Its Ozempic and Wegovy's Strong Brand Recognition (GuruFocus.com)
12:47PM	Novo Nordisk Stock Rises as UBS Upgrades Ozempic Maker, Calls Sell-Off 'Overdone' (Investopedia)
10:06AM	Trump suggests Denmark tariff. How it could hit Novo Nordisk. (Yahoo Finance Video)
09:45AM	This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly (Motley Fool)
09:45AM	5 Questions Novo Nordisk Must Answer to Drive Its Stock Higher (Barrons.com)
08:02AM	Novo Nordisk Faces 5 Key Questions, Says Analyst (Barrons.com)
02:00AM	Novo Nordisk Needs Answers to These 5 Key Questions (Barrons.com)
01:46AM	3 trial readouts that could shake up the obesity market this year (Pharma Voice)
Jan-07-25 05:45PM	Why the Market Dipped But Eli Lilly (LLY) Gained Today (Zacks)
10:00AM	Lilly to participate in J.P. Morgan Healthcare Conference (PR Newswire)
Jan-06-25 01:00PM	Why 2025 will be an inflection for Novo Nordisk, Eli Lilly's GLP-1s (Yahoo Finance Video)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zakrowski Donald A	Officer	Nov 08 '24	Proposed Sale	803.38	900	723,042		Nov 08 04:54 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 08 '24	Sale	803.38	900	723,042	5,480	Nov 08 04:18 PM
Montarce Lucas	EVP & CFO	Nov 01 '24	Option Exercise	0.00	1,074	0	11,541	Nov 05 04:15 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Nov 01 '24	Option Exercise	0.00	1,687	0	31,369	Nov 05 04:14 PM
Dozier Eric	EVP, HR & Diversity	Nov 01 '24	Option Exercise	0.00	1,534	0	8,724	Nov 05 04:13 PM
LILLY ENDOWMENT INC	10% Owner	Sep 03 '24	Sale	966.69	24,084	23,281,840	96,891,978	Sep 04 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 27 '24	Sale	968.46	24,552	23,777,668	96,916,062	Aug 28 04:05 PM
Zakrowski Donald A	Officer	Aug 26 '24	Proposed Sale	950.00	750	712,500		Aug 26 04:47 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 26 '24	Sale	950.00	750	712,500	6,380	Aug 26 04:21 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Sale	966.33	3,196	3,088,382	96,940,614	Aug 23 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Proposed Sale	951.97	215,000	204,673,550		Aug 22 12:54 PM
LILLY ENDOWMENT INC	10% Owner	Jul 10 '24	Sale	939.82	210,000	197,361,398	96,943,810	Jul 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 08 '24	Sale	918.64	93,593	85,977,954	97,153,810	Jul 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 05 '24	Sale	915.18	52,369	47,927,194	97,247,403	Jul 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 03 '24	Sale	915.31	8,848	8,098,655	97,299,772	Jul 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 01 '24	Sale	915.26	58,749	53,770,776	97,308,620	Jul 02 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 28 '24	Sale	915.02	1,441	1,318,545	97,367,369	Jul 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 25 '24	Sale	903.82	188,100	170,009,262	97,368,810	Jun 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 24 '24	Sale	902.38	17,229	15,547,068	97,556,910	Jun 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 20 '24	Sale	902.67	9,671	8,729,733	97,574,139	Jun 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 17 '24	Sale	885.91	194,978	172,733,708	97,583,810	Jun 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 14 '24	Sale	882.47	15,022	13,256,490	97,778,788	Jun 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 10 '24	Sale	860.78	75,510	64,997,274	97,793,810	Jun 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 07 '24	Sale	852.29	139,490	118,886,587	97,869,320	Jun 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 06 '24	Sale	837.82	179,617	150,485,878	98,008,810	Jun 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 05 '24	Sale	836.32	20,383	17,046,673	98,188,427	Jun 06 04:00 PM
Rau Diogo	EVP & CIDO	Jun 01 '24	Option Exercise	0.00	6,300	0	14,146	Jun 04 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Jun 03 '24	Sale	829.77	192,794	159,974,050	98,208,810	Jun 04 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Jun 03 '24	Sale	819.47	750	614,602	7,130	Jun 03 04:15 PM
Norton Johna	EVP, Global Quality	Jun 03 '24	Sale	819.38	7,056	5,781,545	25,428	Jun 03 04:14 PM
LILLY ENDOWMENT INC	10% Owner	May 31 '24	Sale	822.11	22,206	18,255,871	98,401,604	Jun 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 29 '24	Sale	811.04	130,385	105,747,975	98,423,810	May 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 28 '24	Sale	809.00	2,052	1,660,068	98,554,195	May 29 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 24 '24	Sale	809.21	92,563	74,902,998	98,556,247	May 28 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 23 '24	Sale	809.99	50,767	41,120,963	98,648,810	May 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 22 '24	Sale	804.18	12,974	10,433,483	98,699,577	May 23 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 21 '24	Sale	805.45	186,259	150,021,694	98,712,551	May 22 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 11 '24	Sale	753.60	750	565,200	7,880	Mar 11 04:27 PM
LILLY ENDOWMENT INC	10% Owner	Feb 16 '24	Sale	780.99	169,684	132,521,930	98,898,810	Feb 20 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 15 '24	Sale	760.46	50,316	38,263,417	99,068,494	Feb 16 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 09 '24	Sale	740.60	206,257	152,753,428	99,118,810	Feb 12 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 08 '24	Sale	740.06	8,743	6,470,336	99,325,067	Feb 09 04:05 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '24	Option Exercise	0.00	4,442	0	26,631	Feb 02 04:32 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '24	Option Exercise	0.00	3,702	0	16,676	Feb 02 04:29 PM
Ricks David A	President, Chair, and CEO	Feb 01 '24	Option Exercise	0.00	29,611	0	455,054	Feb 02 04:28 PM
Jonsson Patrik	EVP&Pres, LLY Dia&Obe, LLY USA	Feb 01 '24	Option Exercise	0.00	4,124	0	41,065	Feb 02 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '24	Option Exercise	0.00	9,941	0	115,262	Feb 02 04:25 PM
Norton Johna	EVP, Global Quality	Feb 01 '24	Option Exercise	0.00	1,268	0	31,382	Feb 02 04:24 PM
Van Naarden Jacob	EVP & Pres., Loxo@Lilly	Feb 01 '24	Option Exercise	0.00	3,618	0	15,463	Feb 02 04:22 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '24	Option Exercise	0.00	4,124	0	62,050	Feb 02 04:20 PM
LILLY ENDOWMENT INC	10% Owner	Jan 31 '24	Sale	648.07	78,573	50,920,924	99,333,810	Feb 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 30 '24	Sale	645.22	76,215	49,175,200	99,412,383	Jan 31 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 29 '24	Sale	645.07	54,032	34,854,422	99,488,598	Jan 30 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience